Add Company
Join Now

ScPharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • ScPharmaceuticals's estimated annual revenue is currently $7.5M per year.(i)
  • ScPharmaceuticals's estimated revenue per employee is $60,000
  • ScPharmaceuticals's current valuation is $111.9M. (January 2022)

Employee Data

  • ScPharmaceuticals has 125 Employees.(i)
  • ScPharmaceuticals grew their employee count by 42% last year.

ScPharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Medical AffairsReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP Supply Chain and ManufacturingReveal Email/Phone
5
SVP, Clinical Development and Medical AffairsReveal Email/Phone
6
Head Quality AssuranceReveal Email/Phone
7
VP, Legal Affairs & ComplianceReveal Email/Phone
8
VP, Head Regulatory AffairsReveal Email/Phone
9
Head Corporate Affairs and HRReveal Email/Phone
10
VP Program Management and Regulatory AffairsReveal Email/Phone

What Is ScPharmaceuticals?

keywords:N/A

N/A

Total Funding

125

Number of Employees

$7.5M

Revenue (est)

42%

Employee Growth %

$111.9M

Valuation

N/A

Accelerator

ScPharmaceuticals News

2022-04-06 - Scpharmaceuticals Inc (SCPH) Stock Loses -13.69% This Week; Should You Buy?

Scpharmaceuticals Inc (SCPH) stock is down -13.28% over the last 12 months, and the average rating from Wall Street analysts is a Buy.

2022-04-06 - scPharmaceuticals Inc. Announces Resubmission of ...

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application. Anticipates Q4 2022 commercial launch, if approved. April 11,...

2022-04-06 - 5Am Partners Iv, Llc Sells 270000 Shares of ...

scPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) major shareholder 5Am Partners Iv, Llc sold 270,000 shares of the business's stock in a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.5M1253%N/A
#2
$33.8M1254%N/A
#3
$12.5M1254%N/A
#4
$18.8M125-7%N/A
#5
$26.3M12520%N/A